Objective: Advanced imaging can inform risk assessment and preventive/therapeutic decision‐making to enhance care. It is not known how quantification of body fat distribution using advanced imaging and communication of the result through a graphic report may impact cardiometabolic risk factors and attitudes/behaviors among persons living with overweight or obesity. The BODY‐REAL study assessed whether providing patients with (1) visual body fat MRI reports compared with the weight/body mass index (BMI) alone and (2) direct‐to‐patient reports versus through providers would improve cardiometabolic risk among individuals at elevated cardiometabolic risk. Methods: Participants were randomized in a 2 × 2 factorial design to receive a BMI or MRI body fat distribution report, provided direct‐to‐patient report or a report through their healthcare provider. Clinical and psychosocial outcomes were measured at 2 weeks, 3, and 6 months and compared using analysis of covariance and linear models with both fixed and random (time‐updated) effects. Results: 29 participants (31% female, mean BMI 33.6 kg/m 2 ) were randomized. After 6 months of follow‐up, MRI report recipients had lower fasting glucose and higher physical activity scores ( p < 0.01). Provider‐mediated reporting demonstrated greater medication adherence ( p = 0.01) and greater perception of personal control of diabetes ( p = 0.02) but lower perception of diabetes‐related risk ( p = 0.003). There were no significant differences in BMI, blood pressure, cholesterol, glycosylated hemoglobin, or other risk perception across study arms. Conclusions: This pilot feasibility study demonstrated potential for direct‐to‐patient visualization of body fat distribution to improve risk markers and preventive behaviors. Further investigation in a sufficiently powered study is warranted. Trial Registration: ClinicalTrials.gov NCT04763772